Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Chemical hair straightening improves smoothness and shine but may cause side effects, suggesting a need for safer methods.

Curcumin nanocrystal gel improves skin absorption and is safe and effective for topical use.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

Trichoscopy can help diagnose and monitor the progression of dissecting cellulitis.

Hair loss in lupus patients indicates higher disease activity.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Tailored combination therapy improves non-scarring alopecia outcomes.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Dermoscopy helped correctly diagnose a skin condition that was previously misidentified as a different hair loss disease.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Combining PRP and MSCs improves skin healing and structure.

A new computer tool quickly measures hair thickness differences in people with common types of hair loss.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Proper education can prevent traction alopecia in women of color.